These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11169581)

  • 1. The "vanishing counting bead" phenomenon: effect on absolute CD34+ cell counting in phosphate-buffered saline-diluted leukapheresis samples.
    Brando B; Göhde W; Scarpati B; D'Avanzo G;
    Cytometry; 2001 Feb; 43(2):154-60. PubMed ID: 11169581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. True volumetric counting of CD34+ cells using flow cytometry.
    Rico LG; Bardina J; Salvia R; Ward MD; Bradford JA; Petriz J
    J Immunol Methods; 2024 Apr; 527():113649. PubMed ID: 38395105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, randomized, sequential, crossover trial of large-volume vs. normal-volume leukapheresis procedures: effects on subpopulations of CD34(+) cells.
    Humpe A; Riggert J; Koch S; Legler TJ; Munzel U; Köhler M
    J Clin Apher; 2001; 16(3):109-13. PubMed ID: 11746535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.
    Gajkowska A; Oldak T; Jastrzewska M; Machaj EK; Walewski J; Kraszewska E; Pojda Z
    Folia Histochem Cytobiol; 2006; 44(1):53-60. PubMed ID: 16584093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells.
    Menéndez P; Redondo O; Rodriguez A; Lopez-Berges MC; Ercilla G; López A; Durán A; Almeida J; Pérez-Simón JA; San Miguel JF; Gratama JW; Orfao A
    Cytometry; 1998 Dec; 34(6):264-71. PubMed ID: 9879643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. True volumetric method for flow cytometric enumeration of CD34 + stem cells and its agreement with a standard bead-based single-platform protocol.
    Mortazavi S; Ardalan FA; Nodehi SR; Karder FF; Miraliakbari N
    Cytotherapy; 2012 May; 14(5):621-9. PubMed ID: 22428601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of CD34+ cells during large-volume leukapheresis.
    Moller AK; Dickmeiss E; Geisler CH; Christensen LD
    J Hematother Stem Cell Res; 2001 Dec; 10(6):837-53. PubMed ID: 11798510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.
    Keeney M; Chin-Yee I; Weir K; Popma J; Nayar R; Sutherland DR
    Cytometry; 1998 Apr; 34(2):61-70. PubMed ID: 9579602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
    J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enumeration of CD34+ cells in cord blood: a variation on a single-platform flow cytometric method based on the ISHAGE gating strategy.
    Brocklebank AM; Sparrow RL
    Cytometry; 2001 Aug; 46(4):254-61. PubMed ID: 11514960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells.
    de Fabritiis P; Gonzalez M; Meloni G; De Propris MS; Bellucci R; Cordone I; Gozzer M; Leone G; Mandelli F
    Bone Marrow Transplant; 1999 Jun; 23(12):1229-36. PubMed ID: 10414908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of absolute concentration and viability of CD34+ cells in cord blood and cord blood products using fluorescent beads and cyanine nucleic acid dyes.
    Hübl W; Iturraspe J; Martinez GA; Hutcheson CE; Roberts CG; Fisk DD; Sugrue MW; Wingard JR; Braylan RC
    Cytometry; 1998 Jun; 34(3):121-7. PubMed ID: 9696156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collection].
    Galtseva IV; Davydova YO; Gaponova TV; Kapranov NM; Kuzmina LA; Troitskaya VV; Gribanova EO; Kravchenko SK; Mangasarova YK; Zvonkov EE; Parovichnikova EN; Mendeleeva LP; Savchenko VG
    Ter Arkh; 2017; 89(7):18-24. PubMed ID: 28766536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counting of leukocytes in samples from G-CSF mobilized donors, leukapheresis products, and cord blood: the performances of an analyzer with dedicated profiles.
    Pierelli L; Fioravanti D; Patti D; Iudicone P; Scocchera R; Pandolfi A; Nuti M
    Int J Lab Hematol; 2012 Apr; 34(2):154-63. PubMed ID: 21895988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hematopoietic Progenitor Cell Count as an Indicator for Optimal Timing of Peripheral Stem Cell Harvest in Clinical Practice.
    Tanaka H; Ishii A; Sugita Y; Shimizu R; Sato F; Sakuma Y; Iwai R; Kakuta S
    J Clin Exp Hematop; 2017; 56(3):150-159. PubMed ID: 28331129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.
    Díaz MA; Garcia-Sanchez F; Lillo R; Vicent MG; Vicario JL; Madero L
    Haematologica; 1999 Jan; 84(1):32-5. PubMed ID: 10091391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses.
    Dobo I; Robillard N; Pineau D; Geneviève F; Piard N; Rapp MJ; Boasson M; Zandecki M; Hermouet S
    Ann Hematol; 2001 Nov; 80(11):639-46. PubMed ID: 11757722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.
    Chin-Yee IH; Keeney M; Stewart AK; Belch A; Bence-Buckler I; Couban S; Howson-Jan K; Rubinger M; Stewart D; Sutherland R; Paragamian V; Bhatia M; Foley R
    Bone Marrow Transplant; 2002 Dec; 30(12):851-60. PubMed ID: 12476276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPC enumeration with the Sysmex XE-2100 can guide further flow cytometric CD34(+) measurements and timing of leukaphereses.
    Oelschlaegel U; Bornhaeuser M; Thiede C; Ehninger G; Hoelig K
    Cytotherapy; 2003; 5(5):414-9. PubMed ID: 14578103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.